Buy or sell Deep Genomics stock pre IPO via an EquityZen fund
Deep Genomics Stock
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.
About Deep Genomics Stock
The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
Research Scientist & Engineer
Hui Yuan Xiong
Co-Founder and CEO
How Machine Learning Is Crafting Precision Medicine
Forbes - Feb, 11 2019
Khosla Backs AI Startup Creating New Class of Genetic Drugs
Wall Streets Journal - Sep, 25 2017